Procainamide Hydrochloride Extended-Release Tablets

This is a preview of
USP-NF/PF content.

Subscriber?
Access here! Not a subscriber?
Learn more!

» Procainamide Hydrochloride Extended-Release Tablets contain not less than 93.0 percent and not more than 107.0 percent of the labeled amount of procainamide hydrochloride (C₁₃H₂₁N₃O·HCl).

USP REFERENCE STANDARDS FOR PURCHASE

USP Procainamide Hydrochloride RS

This is a preview of
USP-NF/PF content.

Subscriber?
Access here!Not a subscriber?
Learn more!